SpringWorks Therapeutics
SWTX
$43.35
Share price
-7.45%
Change (1 day)
85.89%
Change (1 year)
Categories
SpringWorks Therapeutics (SWTX) - Cash on Hand
Cash on Hand as of December 2023 : $0.47 B
According to SpringWorks Therapeutics's latest financial reports the company has $0.47 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
SpringWorks Therapeutics - Cash on Hand chart (from 2018 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.47 B | -19.08% |
| 2022-12-31 | $0.59 B | 58.56% |
| 2021-12-31 | $0.37 B | -26.55% |
| 2020-12-31 | $0.50 B | 55.19% |
| 2019-12-31 | $0.32 B | 617.78% |
| 2018-12-31 | $45.64 M | 344.44% |
| 2017-12-31 | $10.27 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | -56.56% | 🇺🇸 USA |